Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,637 | 391,000 | 117,432 | 45,653 | 18,987 |
| Depreciation Amortization | 2,540 | 6,336 | 4,082 | 2,234 | 835 |
| Income taxes - deferred | -94 | -249,879 | N/A | N/A | N/A |
| Accounts receivable | -13,893 | -22,718 | -17,111 | -8,766 | -7,004 |
| Accounts payable and accrued liabilities | 1,343 | -5,289 | 5,555 | 3,905 | 1,903 |
| Other Working Capital | 13,200 | -89,756 | -1,847 | 10,672 | -10,879 |
| Other Operating Activity | 27,248 | 80,142 | 50,456 | 30,581 | 16,481 |
| Operating Cash Flow | $33,981 | $109,836 | $158,567 | $84,279 | $20,323 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,493 | -692,565 | -534,951 | -330,398 | -25,211 |
| PPE Investments | -5,212 | -4,690 | -685 | -297 | N/A |
| Sale Of Investment | N/A | 493,529 | 387,779 | 262,190 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -98,838 | -98,838 | -98,838 |
| Other Investing Activity | 0 | -98,838 | -98,838 | -98,838 | -98,838 |
| Investing Cash Flow | $66,281 | $-302,564 | $-246,695 | $-167,343 | $-124,049 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,231 | 49,883 | 27,217 | 17,794 | 1,838 |
| Financing Cash Flow | $4,231 | $49,883 | $27,217 | $17,794 | $1,838 |
| Exchange Rate Effect | 25 | 26 | 19 | 19 | -5 |
| Beginning Cash Position | 185,540 | 328,359 | 328,359 | 328,359 | 328,359 |
| End Cash Position | 290,058 | 185,540 | 267,467 | 263,108 | 226,466 |
| Net Cash Flow | $104,518 | $-142,819 | $-60,892 | $-65,251 | $-101,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,981 | 109,836 | 158,567 | 84,279 | 20,323 |
| Capital Expenditure | -5,212 | -4,690 | -685 | -297 | N/A |
| Free Cash Flow | 28,769 | 105,146 | 157,882 | 83,982 | 20,323 |